Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in...

Area of Science:

• Public Health
• Infectious Disease Prevention
• Behavioral Science

Background:

• Antiretroviral pre-exposure prophylaxis (PrEP) is a key strategy for HIV prevention.
• Anticipation of clinical trial results necessitates proactive examination of PrEP implementation challenges.
• Current strategies acknowledge the need for risk-reduction counseling and HIV testing alongside PrEP drugs.

Purpose of the Study:

• To propose an integrated structure for optimizing the clinical delivery of PrEP.
• To outline essential components beyond medication for effective population-level HIV prevention.
• To highlight critical factors for successful PrEP scale-up in clinical and community settings.

Main Methods:

• This commentary proposes a five-component framework for PrEP delivery.
• The framework integrates pharmaceutical and non-pharmaceutical elements.
• It reviews each component and discusses implementation implications.

Main Results:

• An optimized PrEP delivery structure requires five key components: PrEP drugs, safety screening/HIV testing, behavioral interventions, long-term engagement strategies, and population-level monitoring.
• Addressing non-pharmaceutical elements is crucial for successful implementation.
• Planning for scale-up must consider a wide range of clinical, diagnostic, behavioral, and monitoring services.

Conclusions:

• Effective population-level HIV prevention with PrEP necessitates a comprehensive, integrated approach.
• Successful PrEP implementation hinges on combining medication with robust support services.
• Failure to address the multifaceted needs of PrEP users and healthcare systems may impede its effectiveness as a public health strategy.